Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, reviews the trends from the latest approvals data from the medical devices regulator. The UK’s medical device sector is entering a period of unprecedented momentum, with new
BIOTRONIK has announced the launch of the new Acticor Sky and Rivacor Sky device family featuring the world’s first CE-approved left bundle branch area pacing (LBBAP) high-voltage device. These next-generation implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy defib
TANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd. a company engaged in the industrial precious metals business of TANAKA, has announced that it has established a total solution system capable of supporting all processes in the contract manufacturing business for various test kits including in vitro diagn
Scottish company Airglove Medical has announced the launch of Airglove v2, an air warming system, developed to enhance vein physiology prior to venepuncture and improve access in patients with difficult intravenous access. The company says it is a proven patient solution to make cannulation easier,
MD&M West took place from February 3-5, 2026 in Anaheim, California, with over 1,700 exhibitors and an estimated 13,000+ attendees. I was on site at the event, talking to a range of companies about the latest developments in medical device manufacturing. Over a series of 13 interviews, I spoke to en
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, identifies a new consultation launched by the UK’s MedTech regulator. The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on pro
Neupulse, a neurotherapeutics company focused on delivering innovative solutions to people with brain health conditions, like Tourette Syndrome, has announced it has successfully raised 3 million GBP in new funding. The round was led by Eos Advisory and the Midlands Engine Investment Fund II, throug
Abbott has announced its Volt Pulsed Field Ablation (PFA) System is being used in procedures across the UK to treat people with atrial fibrillation (AFib). Fifteen NHS hospitals are taking part in a pioneering pilot that seeks to confirm the positive impact the Volt PFA System could have on patients
Editor Oli Johnson speaks to BioInteractions Commercial Director Arjun Luthra at MD&M West about the company’s portfolio of coatings, particularly its Assist product, which it highlighted at the show.
At MD&M West, Editor Oli Johnson speaks to Ryan de Leuze and Mike Skaja of Mantle about the use of the company’s 3D printing technology in the manufacture of medical devices, and the role it is playing in the next generation of devices.
Editor Oli Johnson speaks to HiArc Vice President of Engineering and Innovation Tim Patno at MD&M West about the launch of the company’s first commercial product and its debut at the show.
At MD&M West, Editor Oli Johnson speaks to LaserLinc CEO & Co-Founder Jeff Kohler about the company’s recent brand refresh and the evolution of the company.
